Congress Should Boost FDA Funding for Inspections, Science Board Says
This article was originally published in The Gold Sheet
Executive SummarySo many investigators, scientists needed that Congress is urged to double FDA’s budget
You may also be interested in...
The pharmaceutical industry would lose bid to eliminate PUPSIT but win relaxed WFI in proposed EU GMP Annex I revision.
The FDA’s OPQ touts approval of sixth and seventh continuously manufactured drugs and quicker delivery of inspection results in latest annual report.
Nearly 500 shipments of illegal and unapproved prescription drugs and combination medical devices were seized at US borders thanks to Operation Broadsword.